Announcement | Aug 3, 2026Honigman Represents Nuwellis in $3.4 Million Financing

Honigman recently advised Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, in connection with its registered direct offering of 1,310,890 shares of common stock and concurrent private placement of warrants to purchase 1,310,890 shares of common stock, for gross proceeds of approximately $3.4 million.

The offering was priced at $2.59 per share of common stock and accompanying warrant. The warrants have an exercise price of $2.59 per share and are immediately exercisable for five years from issuance.

The Honigman team was led by Corporate Partners Phillip D. Torrence, N. Danny Shulman, Jessica M. Herron, and Michael J. Rosenberg, with support from Associates Daniel Altshuller and Sarah Meinel.